| 751418 |
FRONTIERS IN ONCOLOGY |
Comparison of PET/CT and MRI in the Diagnosis of Bone Metastasis in Prostate Cancer Patients: A Network Analysis of Diagnostic Studies |
2021-10-04 |
10.3389/fonc.2021.736654 |
Liu Fanxiao, Dong Jinlei, Shen Yelong, Yun Canhua, Wang Ruixiao, Wang Ganggang, Tan Jiyang, Wang Tao, Yao Qun, Wang Bomin, Li Lianxin, Mi Jingyi, Zhou Dongsheng, Xiong Fei |
| 751417 |
FRONTIERS IN ONCOLOGY |
Influence of American Society of Anesthesiologists Score on Oncologic Outcomes in Patients With Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy: A Large-Sample Study in Two Institutions |
2021-10-04 |
10.3389/fonc.2021.723669 |
Yuan Yichu, Wang Yiqiu, Zhang Nan, Mao Xiawa, Huang Yiran, Huang Jiwei, Ji Na |
| 751416 |
FRONTIERS IN ONCOLOGY |
Diagnostic and Prognostic Potential of 18F-FET PET in the Differential Diagnosis of Glioma Recurrence and Treatment-Induced Changes After Chemoradiation Therapy |
2021-10-04 |
10.3389/fonc.2021.721821 |
Celli Monica, Caroli Paola, Amadori Elena, Arpa Donatella, Gurrieri Lorena, Ghigi Giulia, Cenni Patrizia, Paganelli Giovanni, Matteucci Federica |
| 751415 |
FRONTIERS IN ONCOLOGY |
CCL23 in Balancing the Act of Endoplasmic Reticulum Stress and Antitumor Immunity in Hepatocellular Carcinoma |
2021-10-04 |
10.3389/fonc.2021.727583 |
Karan Dev |
| 751414 |
FRONTIERS IN ONCOLOGY |
Patient-Derived Xenografts Are a Reliable Preclinical Model for the Personalized Treatment of Epithelial Ovarian Cancer |
2021-10-04 |
10.3389/fonc.2021.744256 |
Chen Jiayu, Jin Ying, Li Siyi, Qiao Cui, Peng Xinxin, Li Yan, Gu Yu, Wang Wei, You Yan, Yin Jie, Shan Ying, Wang Yong-Xue, Qin Meng, Li Hongyue, Cai Yan, Dong Yu, Peng Siying, Pan Lingya |
| 751413 |
FRONTIERS IN ONCOLOGY |
Editorial: Repurposed Drugs Targeting Cancer Signaling Pathways: Dissecting New Mechanism of Action Through In Vitro and In Vivo Analyses |
2021-10-04 |
10.3389/fonc.2021.773429 |
López-Urrutia Eduardo, Padilla-Benavides Teresita, Pérez-Plasencia Carlos, Campos-Parra Alma D. |
| 751412 |
FRONTIERS IN ONCOLOGY |
SPRY4-AS1, A Novel Enhancer RNA, Is a Potential Novel Prognostic Biomarker and Therapeutic Target for Hepatocellular Carcinoma |
2021-10-04 |
10.3389/fonc.2021.765484 |
Ye Mu, Wang Sheng, Qie Jing-bo, Sun Pei-long |
| 751411 |
FRONTIERS IN ONCOLOGY |
Deep Learning Radiomics to Predict PTEN Mutation Status From Magnetic Resonance Imaging in Patients With Glioma |
2021-10-04 |
10.3389/fonc.2021.734433 |
Chen Hongyu, Lin Fuhua, Zhang Jinming, Lv Xiaofei, Zhou Jian, Li Zhi-Cheng, Chen Yinsheng |
| 751410 |
FRONTIERS IN ONCOLOGY |
The Clinical Implications and Molecular Mechanism of CX3CL1 Expression in Urothelial Bladder Cancer |
2021-10-04 |
10.3389/fonc.2021.752860 |
Jiang Guangliang, Wang Hui, Huang Da, Wu Yishuo, Ding Weihong, Zhou Qidong, Ding Qiang, Zhang Ning, Na Rong, Xu Ke |
| 751409 |
FRONTIERS IN ONCOLOGY |
Honokiol Suppresses Perineural Invasion of Pancreatic Cancer by Inhibiting SMAD2/3 Signaling |
2021-10-04 |
10.3389/fonc.2021.728583 |
Qin Tao, Li Jie, Xiao Ying, Wang Xueni, Gong Mengyuan, Wang Qiqi, Zhu Zeen, Zhang Simei, Zhang Wunai, Cao Fang, Han Liang, Wang Zheng, Ma Qingyong, Sha Huanchen |
